BiotechnologyManaged AI Agents

Biotechnology AI Agents,
Monitored for Integrity

Nestack Agent Care helps biotech organizations monitor, evaluate, and optimize AI agents used for research analysis, protocol drafting, data management, and trial operations — before small AI errors become integrity or compliance failures.

180failure modes
82SEV-1 failure modes
1660+baseline eval cases
24/7Agent Monitoring

Scope

Biotechnology AI agents we build & manage

AI agents designed for research, clinical operations, safety, regulatory affairs, quality and GMP, research governance, manufacturing, and commercial workflows.

Observability

What we make observable

Every biotechnology agent session is traced across ten layers — what we capture and the evidence we keep.

  1. Evidence we keep
    Goalconstraintsapproval requirement
  2. Evidence we keep
    Sourceversiontimestamprelevancecitation
  3. Evidence we keep
    Planned sequenceactual sequenceworkflow status
  4. Evidence we keep
    Task statusresultretryfailure reason
  5. Evidence we keep
    Tool nameversioninputoutputpermissionresult
  6. Evidence we keep
    Model/versioninput/outputtoken usagelatencycost
  7. Evidence we keep
    Evaluation typemetricthresholdresult
  8. Evidence we keep
    Guardrail targettriggeractionenforcement result
  9. Evidence we keep
    Reviewerdecisioncorrectionreason
  10. Evidence we keep
    Outcome statusbusiness resultlinked trace

Catalog

Failure modes

Filter failure modes by where they occur in the agent lifecycle—from goals and retrieval to tools, evaluations, guardrails and outcomes.

Nothing on this page matches that. Try a layer (tool, retrieval, guardrail), a code, or a severity.

0 documented↑↓ move · ↵ open · ⌘↵ filter matrix
180 documented · select a cell to filter
8
61
42
94
11
33
80
36
30
144
BIO-01Protocol hallucination — concentrations, temperatures, timings, reagentsSEV-1
BIO-02Biosafety guidance errors — containment levels, spill response, wasteSEV-1
BIO-03IP / trade-secret leakage — sequences, constructs, unpublished resultsSEV-1
BIO-04Literature miscitation — wrong findings attributed to real papersSEV-2
BIO-05Trial-data transcription errorsSEV-1
BIO-06Regulatory-submission format/content errorsSEV-2
BIO-07Dual-use boundary violations — synthesis routes, enhancement queriesSEV-1
BIO-08Sample-tracking mismatches — LIMS IDs, chain of custodySEV-2
BIO-09Statistical and bioinformatics analysis errors — wrong test, batch effects, p-hackingSEV-2
BIO-10Adverse-event under-reporting — SAE not flagged or escalatedSEV-1
BIO-11Consent and protocol-deviation errors — IRB scope, eligibility, versioningSEV-1
BIO-12Cold-chain and reagent-stability errors — temperature, expiry, excursionsSEV-2
BIO-13Concentration and dilution conversion errors — molarity, dosing, unit mix-upsSEV-2
BIO-14Data-integrity documentation failures — ALCOA+, records, audit trailSEV-2
BIO-15Gene-symbol and identifier corruption — Excel autocorrect, HGNC nomenclature drift, accession manglingSEV-2
BIO-16Biosecurity sequence-screening evasion — functional homologs, split synthesis ordersSEV-1
BIO-17Cell-line misidentification — unauthenticated or cross-contaminated linesSEV-2
BIO-18Clinical variant misclassification — ACMG/AMP criteria, VUS vs. pathogenicSEV-1
BIO-19Guide-RNA and off-target design errors — specificity score, PAM, genome buildSEV-2
BIO-20Pharmacovigilance coding errors — MedDRA terms, E2B(R3) format, dictionary versionSEV-2
BIO-21Batch-record and deviation-review errors — completeness, CAPA closure, dispositionSEV-1
BIO-22Patient re-identification and PHI / genomic-data leakageSEV-1
BIO-23Indirect prompt injection via ingested documents and tool outputsSEV-1
BIO-24Trial blinding and randomization-integrity breaches — accidental unblindingSEV-1
BIO-25Export-control and select-agent governance errors — deemed exports, EAR, FSAPSEV-1
BIO-26Assay QC misinterpretation — Westgard rules, OOS/OOT, out-of-control runsSEV-2

A · Research-literature copilots

LR-01Retraction arrives after the copy01 · SearchSEV-1
LR-02Strategy will not rerun01 · SearchSEV-3
LR-03Preprint status lost in the pack02 · ScreeningSEV-2
LR-04Source does not carry the claim03 · ExtractionSEV-1
LR-05Wrong arm or timepoint extracted03 · ExtractionSEV-2
LR-06Safety report left in the pack04 · Pack / outputSEV-1
LR-07Corpus narrows between runs05 · Change / VersionSEV-3

B · Lab-protocol assistants

LP-01Drafted from a superseded version01 · Intake / retrievalSEV-1
LP-02Impacted document left off the list02 · ImpactSEV-2
LP-03Retraining not raised02 · ImpactSEV-2
LP-04Hazard or waste step not carried03 · DraftingSEV-1
LP-05Template sentence left in the method03 · DraftingSEV-2
LP-06Draft worked from as if effective04 · Pack / outputSEV-1
LP-07Silent drafting-rule regression05 · Change / VersionSEV-3

C · Clinical-trial support agents

TR-01Compared against a superseded protocol01 · Intake / retrievalSEV-1
TR-02Consent version not read at the visit01 · Intake / retrievalSEV-2
TR-03Deviation left off the list02 · ComparisonSEV-1
TR-04Query raised against data that is right02 · ComparisonSEV-3
TR-05Treatment-revealing value in a query03 · DraftingSEV-1
TR-06Safety signal handled as a data issue04 · Pack / outputSEV-1
TR-07Silent rule change moves the findings05 · Change / VersionSEV-3

D · Regulatory-submission helpers

RS-01Sequence history read short01 · Intake / retrievalSEV-1
RS-02Placed at the wrong node02 · PlacementSEV-2
RS-03Operation set on the wrong leaf02 · PlacementSEV-1
RS-04Validated on an old profile03 · ValidationSEV-3
RS-05Plan entry read as covered04 · Pack / outputSEV-1
RS-06Clock spent inside assembly04 · Pack / outputSEV-3
RS-07Granularity moves between sequences05 · Change / VersionSEV-2

E · LIMS / sample-tracking agents

LS-01Custody gap reads as a clean chain01 · Intake / loginSEV-1
LS-02Aliquot inherits the wrong parent01 · Intake / loginSEV-2
LS-03Excursion smoothed into a period mean02 · TrackingSEV-1
LS-04Reading outside limits raised as a query03 · AssessmentSEV-1
LS-05Cleaner repeat shown as the answer03 · AssessmentSEV-1
LS-06Record reads complete when it is not04 · File / handoffSEV-2
LS-07Limit changed outside change control05 · Change / VersionSEV-3

F · Pharmacovigilance case-processing agents

PV-01Day zero recorded late01 · Intake / receiptSEV-1
PV-02Case missed at intake01 · Intake / receiptSEV-1
PV-03Duplicate entered as new02 · Duplicate searchSEV-2
PV-04Verbatim coded too general03 · CodingSEV-1
PV-05Narrative outruns the source04 · Draft / writeSEV-2
PV-06Follow-up question never put04 · Draft / writeSEV-3
PV-07Silent convention change05 · Change / VersionSEV-2

G · Safety-signal-detection agents

SG-01Exposure that never fitted01 · Data assemblySEV-2
SG-02Smaller signal stays masked02 · Quantitative runSEV-1
SG-03Reporting surge read as risk02 · Quantitative runSEV-3
SG-04Indication read as effect03 · Evidence packageSEV-2
SG-05Ranked by alert, not by harm04 · Queue / outputSEV-1
SG-06Window spent in the tracker04 · Queue / outputSEV-1
SG-07Strata moved without a record05 · Change / VersionSEV-2

H · Medical-writing & CSR-authoring copilots

MW-01Drafted from a superseded lock01 · Intake / retrievalSEV-1
MW-02Output does not exist yet01 · Intake / retrievalSEV-3
MW-03Wording edges into interpretation02 · DraftingSEV-1
MW-04Narrative smoothed past the record02 · DraftingSEV-2
MW-05Right figure, wrong analysis set03 · Source checksSEV-2
MW-06Sections disagree with each other04 · Pack / outputSEV-1
MW-07Output rerun under a finished draft05 · Change / VersionSEV-2

I · GMP batch-record & release agents

GB-01Blank entry reads as complete01 · Intake / recordSEV-1
GB-02Paper insert never reaches the package01 · Intake / recordSEV-2
GB-03Reconciliation short, yield in range02 · CheckingSEV-2
GB-04Late entry passes as contemporaneous02 · CheckingSEV-1
GB-05Exception set narrows the review03 · ExceptionSEV-1
GB-06Deviation shows closed after reopening04 · PackageSEV-2
GB-07Rule change moves the exception line05 · Change / VersionSEV-3

J · Field-rep & pre-call commercial copilots

FP-01Opted-out prescriber planned against01 · Account pictureSEV-2
FP-02Access position out of date01 · Account pictureSEV-3
FP-03Expired piece selected02 · Content selectionSEV-2
FP-04Wrong market or audience02 · Content selectionSEV-2
FP-05Discussion point drifts off label03 · Plan draftingSEV-2
FP-06Event left in the commercial system04 · Record / hand-offSEV-1
FP-07Silent routing regression05 · Change / VersionSEV-1

K · Promotional-content review (MLR) agents

ML-01Superseded label version read01 · Label & referencesSEV-2
ML-02Reference does not say it02 · Claim checkingSEV-1
ML-03Annotated to the file, not the page03 · PresentationSEV-2
ML-04Thin fair balance read as adequate03 · PresentationSEV-1
ML-05Approved elsewhere, packaged here04 · Package / releaseSEV-1
ML-06Expiry passed while it waited04 · Package / releaseSEV-1
ML-07Silent check-rule regression05 · Change / VersionSEV-3

L · Autonomous-lab experimentation agents

AL-01Condition proposed outside the envelope01 · PlanningSEV-1
AL-02Optimiser chases an artefact01 · PlanningSEV-3
AL-03Run started on a lapsed calibration02 · PreconditionsSEV-2
AL-04Deck does not match the plate map02 · PreconditionsSEV-2
AL-05Incompatible work booked together03 · SchedulingSEV-1
AL-06Overnight failure raises nothing04 · ExecutionSEV-1
AL-07Manual intervention never recorded05 · Record / VersionSEV-2

M · Trial registration & results disclosure agents

EG-03Stale registry export01 · RetrievalSEV-3
EG-04Clock read from the wrong date02 · ReasoningSEV-1
EG-06Backstop lost behind a review02 · ReasoningSEV-1
EG-02Cure period never started03 · Tool / writeSEV-1
EG-05Three registers, three counts03 · Tool / writeSEV-2
EG-01Missing results element04 · OutputSEV-2
EG-07Silent clock drift05 · Change / VersionSEV-2

N · Deviation, CAPA & change-control agents

EH-03Prior events missed01 · RetrievalSEV-3
EH-04Scope stops at the batch02 · ReasoningSEV-1
EH-06Cause named as human error02 · ReasoningSEV-1
EH-02Clock started at creation03 · Tool / writeSEV-1
EH-05Effectiveness window early03 · Tool / writeSEV-2
EH-01Change filed nowhere04 · OutputSEV-2
EH-07Silent scope regression05 · Change / VersionSEV-2

O · Research-oversight & attestation evidence agents

EJ-03Superseded framework01 · RetrievalSEV-3
EJ-04Scope sweep too narrow02 · ReasoningSEV-1
EJ-06Amendment read as approved02 · ReasoningSEV-1
EJ-02Attestation never collected03 · Tool / writeSEV-1
EJ-05Person-level clock missed03 · Tool / writeSEV-2
EJ-01Flag ages in a queue04 · OutputSEV-2
EJ-07Silent scope drift05 · Change / VersionSEV-2

P · Aggregate safety report assembly agents

EM-03Scope read as current01 · RetrievalSEV-3
EM-04Denominators totalled02 · ReasoningSEV-1
EM-06Effectivity lag ignored02 · ReasoningSEV-1
EM-02Waiver applied family-wide03 · Tool / writeSEV-1
EM-05Assembled per programme03 · Tool / writeSEV-2
EM-01Reconciled to the database04 · OutputSEV-2
EM-07Silent template carry-forward05 · Change / VersionSEV-2

Q · Supplier, CMO & quality-agreement agents

ER-03Superseded register entry01 · RetrievalSEV-3
ER-04Auditing body misnamed02 · ReasoningSEV-1
ER-06Certificate read as current02 · ReasoningSEV-1
ER-02Notice clock never run03 · Tool / writeSEV-1
ER-05Agreement drifts from practice03 · Tool / writeSEV-2
ER-01Written assessment absent04 · OutputSEV-2
ER-07Silent currency regression05 · Change / VersionSEV-2

R · Out-of-specification investigation agents

ET-03Sequence not pulled01 · RetrievalSEV-3
ET-04Cause named too early02 · ReasoningSEV-1
ET-06Trend limits widen02 · ReasoningSEV-1
ET-02Clock started at entry03 · Tool / writeSEV-1
ET-05Retest count adjusted03 · Tool / writeSEV-2
ET-01Prior failure missed04 · OutputSEV-2
ET-07Silent checklist drift05 · Change / VersionSEV-2

S · Post-approval change & commitment agents

EW-03Superseded register row01 · RetrievalSEV-3
EW-04Milestone read as met02 · ReasoningSEV-1
EW-06One category, every market02 · ReasoningSEV-1
EW-02Guideline keyed to filing03 · Tool / writeSEV-1
EW-05Protocol read as standing03 · Tool / writeSEV-2
EW-01Two clocks, one register04 · OutputSEV-2
EW-07Silent milestone drift05 · Change / VersionSEV-2

T · Animal care & use protocol governance agents

EY-03Rescinded guidance01 · RetrievalSEV-3
EY-04Interval read as a quota02 · ReasoningSEV-1
EY-06Annual cycle enforced02 · ReasoningSEV-1
EY-02Amendment read as decided03 · Tool / writeSEV-1
EY-05Escalation list short03 · Tool / writeSEV-2
EY-01Finding without a date04 · OutputSEV-2
EY-07Silent interval drift05 · Change / VersionSEV-2

U · Safety labelling change & core data sheet agents

EZ-03Notification unowned01 · RetrievalSEV-3
EZ-04Pathway carried over02 · ReasoningSEV-1
EZ-06Extension not re-derived02 · ReasoningSEV-1
EZ-02Cascade misses a market03 · Tool / writeSEV-1
EZ-05Two versions translated03 · Tool / writeSEV-2
EZ-01Divergence unexplained04 · OutputSEV-2
EZ-07Silent matrix drift05 · Change / VersionSEV-2

V · Product quality review assembly agents

FA-03Register read as current01 · RetrievalSEV-3
FA-04Trend crosses a moved limit02 · ReasoningSEV-1
FA-06Conclusion filled in02 · ReasoningSEV-1
FA-02Pack issued unreconciled03 · Tool / writeSEV-1
FA-05Open item carried unchanged03 · Tool / writeSEV-2
FA-01Element left uncovered04 · OutputSEV-2
FA-07Silent element drift05 · Change / VersionSEV-2

Guardrails

Critical guardrails for Biotechnology agents

Ten controls that hold regardless of prompt, plan or pressure. Open one to see what it protects, what trips it, what the agent is forced to do, who may release it, and what is written to the record.

GR-01No lab protocol without verified concentration and reagent valuesOverride defined
  1. Target

    Generated lab protocols specifying concentrations, temperatures, timings, reagents and dilutions

  2. Trigger

    A protocol states a concentration, dilution or reagent value without a verified source

  3. Action — enforced

    Block the protocol and require verified values; agent may return a sourced protocol or flag for review

  4. Human override

    Released only by the responsible scientist after verifying values against the controlled protocol

Logged evidenceprotocol id · parameter · stated value · verified source · scientist identity · timestamp

GR-02No biosafety guidance below required containment levelOverride defined
  1. Target

    Containment, spill-response and waste-handling guidance for biological and hazardous materials

  2. Trigger

    Guidance specifies a containment level or spill response below the required biosafety standard

  3. Action — enforced

    Refuse the unsafe guidance and enforce the required containment; agent may direct to the biosafety officer

  4. Human override

    Released only by the biosafety officer confirming the containment level for the agent and task

Logged evidenceagent or material · proposed level · required level · officer identity · timestamp

GR-03No response advancing dual-use synthesis or screening evasionOverride defined
  1. Target

    Requests touching pathogen enhancement, synthesis routes and sequence-screening bypass techniques

  2. Trigger

    A query seeks enhancement, a synthesis route or a way to evade sequence screening

  3. Action — enforced

    Refuse the request and escalate per dual-use policy; agent may provide only non-actionable, published context

  4. Human override

    Released only by the institutional biosafety committee under documented dual-use review

Logged evidencequery id · dual-use category · refusal basis · escalation ref · reviewer identity · timestamp

GR-04No cross-program IP retrievalNo override
  1. Target

    Sequences, constructs, unpublished results and genomic data scoped to a single program or partner

  2. Trigger

    A request or tool call would read another program IP, partner data or patient genomes

  3. Action — enforced

    Deny the cross-program read and return only in-scope data; agent continues within the program boundary

  4. Human override

    None — cannot be overridden in session

Logged evidencerequesting program · target program · denied asset id · policy rule · timestamp

GR-05No instruction embedded in documents or tool outputs ever executedNo override
  1. Target

    Ingested papers, protocols, LIMS records and tool outputs the agent reads during a task

  2. Trigger

    Ingested documents or tool outputs contain directives or calls attempting to steer the agent

  3. Action — enforced

    Treat the content as data only and refuse the embedded instruction; the analysis task continues normally

  4. Human override

    None — cannot be overridden in session

Logged evidencesource id · detected instruction · artifact type · content hash · timestamp

GR-06No unescalated serious adverse eventOverride defined
  1. Target

    Safety-signal review of trial data, case reports and pharmacovigilance intake for adverse events

  2. Trigger

    Data indicates a serious adverse event yet it is not flagged or escalated for reporting

  3. Action — enforced

    Force the safety escalation and reporting workflow; agent may not downgrade and must preserve the signal

  4. Human override

    Released only by the pharmacovigilance officer after clinical review of the adverse-event signal

Logged evidencecase id · event term · seriousness · escalation route · officer identity · timestamp

GR-07No action risking unblinding or randomisation breachOverride defined
  1. Target

    Randomisation, allocation and blinding controls across the trial data and analysis pipeline

  2. Trigger

    An action would reveal allocation, break the blind or corrupt the randomisation sequence

  3. Action — enforced

    Block the action and preserve the blind; agent may continue on de-identified, allocation-masked data only

  4. Human override

    Released only by the unblinding statistician under the protocol-defined emergency-unblinding procedure

Logged evidencetrial id · subject id · requested action · blinding status · statistician identity · timestamp

GR-08No variant call without ACMG/AMP classification reviewOverride defined
  1. Target

    Clinical variant interpretation and reporting drawing on ACMG/AMP criteria and evidence

  2. Trigger

    A variant is reported as pathogenic or benign without a completed ACMG/AMP criteria review

  3. Action — enforced

    Hold the variant report and require criteria review; agent may return a documented classification with evidence

  4. Human override

    Released only by the clinical molecular geneticist confirming the ACMG/AMP classification and evidence

Logged evidencevariant id · genome build · classification · criteria applied · geneticist identity · timestamp

GR-09No trial record breaching ALCOA+ data integrityOverride defined
  1. Target

    GxP records the agent creates or edits, including trial-data transcription and audit trails

  2. Trigger

    A record write would transcribe data inaccurately or break the ALCOA+ audit trail

  3. Action — enforced

    Block the write and require source verification; agent may log a corrected, attributable entry with audit trail

  4. Human override

    Released only by the quality-assurance officer after verifying the record against source data

Logged evidencerecord id · source reference · before-and-after values · officer identity · timestamp

GR-10No batch disposition without completed deviation reviewOverride defined
  1. Target

    Batch-record disposition, deviation handling and CAPA closure for manufactured lots

  2. Trigger

    A batch is dispositioned with an open deviation, incomplete record or unclosed CAPA

  3. Action — enforced

    Hold the disposition and require review closure; agent may compile the record and route deviations for sign-off

  4. Human override

    Released only by the quality-assurance officer after deviation review and CAPA closure are complete

Logged evidencebatch id · open deviations · CAPA status · disposition · officer identity · timestamp

Oversight

Human review — triggers, decisions and evidence

When a defined risk trigger fires, the affected action is routed to a named reviewer. Every decision is recorded with its correction, escalation and final outcome for full traceability.

  • ConfidenceLow-confidence variant call
  • Financial impactHigh-value procurement
  • Identity / change riskSample or cell-line identity
  • Irreversible actionBatch release or submission
  • Policy riskConsent or protocol deviation
  • Safety controlGuardrail override
  • Quality failureFailed critical evaluation
Humanreviewnamed reviewer
  • Revieweridentity + role
  • Decisionapprove / reject / amend
  • Correctionwhat changed
  • Escalationwho, why and severity
  • Final outcomereleased / blocked / returned for rework

7 triggers · any one halts the agent

1 record · 5 fields, every time

Compliance

Regulatory mapping

  • 01 Goal
  • 02 Retrieval
  • 03 Workflow
  • 04 Task
  • 05 Tool
  • 06 LLM
  • 07 Evaluation
  • 08 Guardrail
  • 09 Human review
  • 10 Outcome

Adverse-event intake & expedited clocks

Fifteen calendar days run from the moment information qualifies, investigators report serious events immediately, and applicants must review adverse experiences from any source. Seriousness turns on outcome, not the term coded.

21 CFR 312.32(c)(1)(i) · 21 CFR 312.64(b) · 21 CFR 314.80(b)

Lifecycle layer:03 Workflow · 04 Task · 08 Guardrail · 10 Outcome

  • BIO-10
  • BIO-20
  • LR-06
  • TR-06
  • PV-01
  • PV-02
  • PV-04
  • PV-06
  • FP-06

Evaluations

Baseline evaluation suite — in detail

Baseline evaluations are completed during onboarding and repeated based on the selected plan. Agents that fail critical checks remain restricted until they pass re-testing.

Detailed case sets
82
Failure modes covered
26
Retired & rotated / quarter
10%
Audit-ready scorecard
Monthly

Output evaluation6 suites · 370 cases

60 casesSubmission-format checkscatches BIO-06
70 casesAnalysis-method setcatches BIO-09
70 casesVariant classificationcatches BIO-18
50 casesGuide-RNA off-target designcatches BIO-19
60 casesPharmacovigilance codingcatches BIO-20
60 casesAssay QC acceptancecatches BIO-26

Use your work email to unlock the full grid. We use it to send the requested Agent Care material and qualify business inquiries. We do not sell or share your email.

  1. Domain-expert review

    Client-designated subject-matter experts review evaluation criteria, pass thresholds and industry-specific risks before baseline approval.

  2. Test-case rotation

    Evaluation cases are refreshed regularly to reduce memorisation, limit overfitting and maintain meaningful performance measurement.

  3. Scorecard integration

    Scorecards compare results with the approved baseline, show performance trends and flag material declines for review and escalation.

  4. Client-specific extensions

    Where included in scope, evaluations may be expanded using approved incidents, workflows, policies, data patterns and industry-specific risks.

Monitoring

Change-aware monitoring

When agent performance changes, Nestack correlates the shift with changes to the agent, prompt, model, tools, knowledge base, guardrails and evaluation suite.

Version changes by layer
01AgentAgent changed in week 4Agent changed in week 11
02PromptPrompt changed in week 6
03ModelModel changed in week 3
04ToolTool changed in week 7
05Knowledge-baseKnowledge-base changed in week 8Knowledge-base changed in week 10
06GuardrailGuardrail changed in week 5Guardrail changed in week 12
07Eval-suiteEval-suite changed in week 10
Protocol-grounding rate92–100%
  • Week 1 · 98.7%
  • Week 2 · 98.6%
  • Week 3 · 98.8%
  • Week 4 · 98.7%
  • Week 5 · 98.9%
  • Week 6 · 98.7%
  • Week 7 · 98.8%
  • Week 8 · 95.1%
  • Week 9 · 94.9%
  • Week 10 · 98.7%
  • Week 11 · 98.8%
  • Week 12 · 98.9%

Week readouthover or select

Week 8of 12

  • 05Knowledge-basekb 2026.07

95.1%Protocol-grounding rate

  • 7 layers stamped on every run · 12-week window
  • Catches BIO-20 · dictionary-version coding errors

Something missing?

Don’t see your agent’s issue here?

Every AI environment is different. Share what you’re seeing, and we’ll review the behaviour, assess the risk and recommend the evaluations or controls that may help.

Report an agent issue

Tell us what you’re seeing

The more specific, the faster we can reproduce it. Playbook: Biotechnology

We reply within one business day.

See pricing

No commitment. Even if you never become a client, we’ll tell you what we think is happening.

Process

Universal incident runbook

Severity is assigned based on business impact, customer harm, data exposure, operational disruption and overall scope.

  • SEV-1 Critical
  • SEV-2 Major
  • SEV-3 Moderate
  • SEV-4 Minor
STEP 01

Automated monitoring or human review identifies unusual behaviour. Alerts are recorded and routed according to severity.

Outcomes

Not just that it ran.
What it delivered.

Observability shows the agent ran. It can’t show the batch was released or what the work cost. Where outcome data exists, we trace each result to its session — and a named reviewer signs off the month.

Issued
Monthly, per engagement
Traced
Every figure to its session
Signed
By your engagement reviewer
Used for
Client reporting, partner review, the AgentOps scorecard

Nestack AgentOps

Biotechnology fleet · monthly statement

  • Protocol step verified5,280
  • Batch record reviewed340
  • Chain of custody closed1,960
  • Adverse-event case processed118
  • Study milestones completed9 of 9
  • Workflows delivered7,698
  • Outcome success rate98.9%
  • Human correction required85 · 1.1%
Average AI cost per successful workflow$0.58

Every figure linked to its source trace · exportable for review and audit support

Cost control

Keep biotechnology AI agent costs under control

Token spend is monitored, optimised and reported as part of Agent Care — and savings never come at the expense of quality, because every change is verified against your evaluation baseline.

We review token spend by agent, workflow, model, and session so you can understand where AI costs are coming from.

Running biotechnology AI agents in production?

Get a free assessment of one agent. We’ll review its behaviour, run a baseline evaluation and highlight potential risks and performance gaps.

Loading open times…

Open times

Select an available date above to view open 45-minute times from our calendar.